Work

A Phase I Study of the Multi-Targeted Tyrosine Kinase Inhibitor Cabozantinib in Patients with Acute Myeloid Leukemia

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.5218.5218

Authors: Amir T. Fathi, Traci M. Blonquist, Mark J. Levis, Daniela Hernandez, Karen K. Ballen, David E. Avigan, Robin Joyce, Malgorzata McMasters, Emma Logan, Gabriela S. Hobbs, Andrew M. Brunner, Christine Connolly, Ashley M. Perry, Christelle Joseph, Tina T. Som, Aura Y. Ramos, Donna S. Neuberg, Philip C. Amrein

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Harvard University, Beth Israel Deaconess Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2617492002

FWCI:

Cites:

Cited by: 4

Related to: 10